New era in Alzheimer's disease therapeutics:transitioning from symptomatic management to disease-modifying paradigmsCHEN Xiao-chun, LIAO Jiang-feng109-111
Consensus on diagnostic criteria for Alzheimer's diseaseCongress of Neuro-Degenerative Diseases Committee of Chinese Society of Microcirculation, LI Yan-feng, JI Yong112-128
Expert consensus on the selection of accessory examinations for cognitive dysfunction disorders based on the biomarker diagnostic frameworkNeurodegenerative Disease Special Committee,China Association for Promotion of Health Science and Technology, Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, BA Mao-wen, WANG Xi-jin129-143
Interpretation of"Specification for interdisciplinary team service of the elderly with cognitive impairment"LI Wen-jie, SONG Yue-tao, LÜ Ji-hui144-151
Comparison between the MIND-China study and similar international large-scale cohort studiesWANG Xiao-yu, DU Yi-feng152-160
Progress on the pathogenesis of Alzheimer's diseaseWANG Pu-yun, WANG Cai-xia, JIA Yan-hong, SUN Yong-jie, LIU Mei-li, LIANG Fu-ru161-168
Advance in the clinical diagnosis and treatment of Alzheimer's diseaseLIAO Jiang-feng, CHEN Xiao-chun179-187
Advance in Lecanemab therapy for Alzheimer's diseaseQIANG Qi-qi, LIU Pei-jie, CUI Si-meng, QU Qiu-min188-193